共 50 条
- [31] To Mesh or Not to Mesh Current Debates in Prolapse Repair Fueled by the U.S. Food and Drug Administration Safety Notification OBSTETRICS AND GYNECOLOGY, 2011, 118 (04): : 771 - 773
- [33] ACMT Position Statement: Position on the Recent Judicial Challenge of U.S. Food and Drug Administration Approval of Mifepristone Journal of Medical Toxicology, 2023, 19 : 414 - 415
- [34] Hysteroscopic Sterilization With Essure Summary of the U.S. Food and Drug Administration Actions and Policy Implications for Postmarketing Surveillance OBSTETRICS AND GYNECOLOGY, 2017, 129 (01): : 10 - 19
- [36] Assessment of the U.S. Food and Drug Administration's risk evaluation and mitigation strategy (REMS) for prasugrel (EFFIENT): A narrative review AMERICAN HEART JOURNAL PLUS: CARDIOLOGY RESEARCH AND PRACTICE, 2024, 38